📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist. (2014)

First Author: Sarvi S
Attributed to:  A hub for Engineering and exploiting the stem cell niche funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-13-1541

PubMed Identifier: 24436149

Publication URI: http://europepmc.org/abstract/MED/24436149

Type: Journal Article/Review

Volume: 74

Parent Publication: Cancer research

Issue: 5

ISSN: 0008-5472